Cx Institutional Bristol Myers Squibb CO Transaction History

Cx Institutional

$2.24 Billion
Q3 2024

A detailed history of Cx Institutional transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cx Institutional holds 132,035 shares of BMY stock, worth $7.02 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

132,035

Previous 72,919 81.07%

Holding current value

$7.02 Million

Previous $3.03 Million 125.63%

% of portfolio

0.3%

Previous 0.14%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$39.66 - $51.75 $2.34 Million - $3.06 Million	59,116 Added 81.07%	132,035 $6.83 Million
Q2 2024 Jul 11, 2024	BUY	$40.25 - $52.99 $398,153 - $524,177	9,892 Added 15.69%	72,919 $3.03 Million
Q1 2024 Apr 15, 2024	SELL	$47.98 - $54.4 $1.23 Million - $1.39 Million	-25,546 Reduced 28.84%	63,027 $3.42 Million
Q4 2023 Jan 12, 2024	BUY	$48.48 - $57.85 $1.39 Million - $1.66 Million	28,749 Added 48.06%	88,573 $4.54 Million
Q3 2023 Oct 17, 2023	SELL	$57.89 - $64.73 $2.45 Million - $2.74 Million	-42,297 Reduced 41.42%	59,824 $3.47 Million
Q2 2023 Jul 26, 2023	BUY	$63.71 - $70.74 $232,923 - $258,625	3,656 Added 3.71%	102,121 $6.53 Million
Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $5.41 Million - $6.13 Million	82,297 Added 509.01%	98,465 $6.82 Million
Q4 2022 Feb 03, 2023	BUY	$68.48 - $81.09 $147,848 - $175,073	2,159 Added 15.41%	16,168 $1.16 Million
Q3 2022 Nov 04, 2022	SELL	$0.13 - $76.84 $1,024 - $605,806	-7,884 Reduced 36.01%	14,009 $996,000
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $1.76 Million - $1.94 Million	-24,255 Reduced 52.56%	21,893 $1.69 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $2.53 Million - $3.03 Million	41,106 Added 815.27%	46,148 $3.37 Million
Q4 2021 Jan 18, 2022	SELL	$53.63 - $62.52 $116,484 - $135,793	-2,172 Reduced 30.11%	5,042 $314,000
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $39,762 - $46,576	-672 Reduced 8.52%	7,214 $427,000
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $85,250 - $92,837	1,377 Added 21.16%	7,886 $527,000
Q1 2021 Apr 15, 2021	BUY	$59.34 - $66.74 $28,839 - $32,435	486 Added 8.07%	6,509 $411,000
Q4 2020 Jan 12, 2021	BUY	$57.74 - $65.43 $59,703 - $67,654	1,034 Added 20.73%	6,023 $374,000
Q3 2020 Oct 13, 2020	BUY	$57.43 - $63.64 $35,836 - $39,711	624 Added 14.3%	4,989 $301,000
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $14,636 - $17,112	267 Added 6.52%	4,365 $237,000
Q1 2020 Apr 29, 2020	SELL	$46.4 - $67.43 $6,867 - $9,979	-148 Reduced 3.49%	4,098 $228,000
Q4 2019 Jan 21, 2020	BUY	$49.21 - $64.19 $18,502 - $24,135	376 Added 9.72%	4,246 $273,000
Q3 2019 Oct 10, 2019	SELL	$42.77 - $50.71 $2,437 - $2,890	-57 Reduced 1.45%	3,870 $196,000
Q2 2019 Jul 17, 2019	SELL	$44.62 - $49.34 $31,903 - $35,278	-715 Reduced 15.4%	3,927 $178,000
Q1 2019 Apr 03, 2019	BUY	$45.12 - $53.8 $11,099 - $13,234	246 Added 5.6%	4,642 $221,000
Q4 2018 Jan 14, 2019	BUY	$48.76 - $63.23 $156,032 - $202,336	3,200 Added 267.56%	4,396 $229,000
Q2 2018 Jul 12, 2018	BUY	$50.53 - $62.98 $60,433 - $75,324	1,196 New	1,196 $76,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.

Account

Cx Institutional Bristol Myers Squibb CO Transaction History